Updates are available Correction dated 2024-08-31
Click to view Correction: https://doi.org/10.1007/s40266-024-01141-w
-
Authors
Ganguly, Anirban
Tyagi, Shachi
Chermansky, Christopher
Kanai, Anthony
Beckel, Jonathan
Hashimoto, Mamoru
Cho, Kang Jun
Chancellor, Michael
Kaufman, Jonathan
Yoshimura, Naoki
Tyagi, Pradeep https://orcid.org/0000-0001-6586-4545
-
Funding
Funding for this research was provided by:
National Institute of Health (R44DK108397)
National Institute of Health (CA251341)
National Institute of Health (CA263243)
- License Information
-
More Information
Article History
Accepted: 26 January 2023
First Online: 6 March 2023
Change Date: 31 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40266-024-01141-w
Declarations
:
: This work was partly supported by National Institutes of Health Grants: R44DK108397, CA251341, and CA263243.
: Michael Chancellor and Jonathan Kaufman are board members of Lipella Pharmaceuticals. Pradeep Tyagi is a consultant for Vensica Therapeutics and Uropharma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: AG and ST wrote the initial draft and performed the literature search; CC, AK, and JB offered valuable suggestions to modify the draft; MC, JK, and NY edited and help secure funding; PT was responsible for the overall theme, direction, and formatting of the submitted work.
